UNC93B1 activators are a diverse class of compounds that indirectly stimulate the function of the UNC93B1 protein. They primarily work by activating various Toll-like receptors (TLRs), key components of the innate immune system that UNC93B1 is known to interact with and support. These chemical activators range from lipopolysaccharides and synthetic lipoproteins to oligodeoxynucleotides and iron chelators.
These compounds can initiate a cascade of intracellular signaling that ultimately leads to UNC93B1 activation. For instance, lipopolysaccharides and synthetic lipoproteins such as Pam3CSK4 and FSL-1 activate TLR1/2 and TLR2/6, respectively. These receptors then initiate an intracellular signaling cascade that involves UNC93B1. Similarly, synthetic oligodeoxynucleotides like Poly(I:C), ODN 2006, and CpG ODN activate TLR3 and TLR9, indirectly stimulating UNC93B1. The iron chelator, SMIP-004, represents another means of indirect activation, where modulation of intracellular iron levels, critical for UNC93B1 function, results in its activation. The commonality among these diverse compounds is their ability to indirectly activate UNC93B1 via modulation of upstream signaling pathways, mainly involving TLRs.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $663.00 | 2 | |
Poly(I:C) is a synthetic analog of double-stranded RNA, which activates TLR3. This can lead to an activation cascade involving UNC93B1. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod is a TLR7 agonist. Its activation of TLR7 can indirectly stimulate UNC93B1. | ||||||
R-848 | 144875-48-9 | sc-203231 sc-203231A sc-203231B sc-203231C | 5 mg 25 mg 100 mg 500 mg | $102.00 $306.00 $510.00 $1559.00 | 12 | |
R-848 (Resiquimod) is another TLR7 agonist, and its activation of TLR7 can lead to UNC93B1 activation. | ||||||
Pam3Cys-Ser-(Lys)4, Hydrochloride | 112208-00-1 | sc-507471 | 2 mg | $550.00 | ||
Pam3CSK4 is a synthetic triacylated lipopeptide that can activate TLR1/2, thereby indirectly activating UNC93B1. | ||||||
Gardiquimod | 1020412-43-4 | sc-221663 sc-221663A sc-221663B sc-221663C sc-221663D sc-221663E sc-221663F | 25 mg 50 mg 100 mg 250 mg 5 g 10 g 25 g | $157.00 $282.00 $516.00 $1177.00 $20138.00 $32779.00 $70753.00 | 1 | |
Gardiquimod is a TLR7 agonist. Its activation of TLR7 can indirectly stimulate UNC93B1. | ||||||
CL097 | 1026249-18-2 | sc-507394 | 5 mg | $135.00 | ||
CL097 is a derivative of CL075, also activating TLR8 and potentially leading to UNC93B1 activation. | ||||||